IDEAYA Biosciences Stock Forecast
NASDAQ: IDYAHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
IDYA analyst consensus
Consensus (14 analysts)
strong_buy
Avg. price target
$52.75+46.28%
- Strong buy 3
- Buy 10
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 14 Wall Street analysts covering IDEAYA Biosciences (2026-10-09), 13 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $52.75, with a high estimate of $65.00 and a low estimate of $31.00. The average target implies upside of 46.3% from the current price of $36.06.
The spread between the highest and lowest targets is 109.7%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for IDYA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 21% |
| Buy | 10 | 71% |
| Hold | 1 | 7% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $31.00 | -14.03% |
| Average target | $52.75 | +46.28% |
| High target | $65.00 | +80.26% |